会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明公开
    • Immunogenic peptides and their use in immune disorders
    • 免疫原性肽及其在免疫疾病中的应用
    • EP2476436A2
    • 2012-07-18
    • EP11187013.5
    • 2007-08-13
    • Life Sciences Research Partners VZW
    • Saint-Remy, Jean-Marie
    • A61K39/35C07K14/435C07K14/47
    • C07K14/4713A61K35/17A61K39/0008A61K39/35A61K2039/572C07K14/415C07K14/43531C07K14/47C07K14/4717C07K14/62C07K2319/00C12N9/0065C12N9/88C12Y111/01008C12Y401/01015
    • The present invention provides novel peptides and homologues thereof. The peptides of the invention comprise (i) a T-cell epitope of an antigen (self or non-self) with a potential to trigger an immune reaction presented by a class II major histocompatibility complex (MHC) determinant and recognised by CD4+ T cell more specifically of an allergen or auto-antigen, coupled, optionally through the use of a linker to (ii) an amino acid sequence having a reducing activity, such as a thioreductase sequence. The peptides of the invention have been shown to be useful a medicine, more in particular for the prevention or treatment of immune disorders, more specifically of allergic disorders or autoimmune diseases. The present invention thus provides for the use of said peptides for the manufacture of a medicament for the prevention or treatment of an immune disorder and further provides for methods of treatment or preventing immune disorders by using said peptides. The present invention also provides for compositions comprising said peptides.
    • 本发明提供了新的肽及其同系物。 本发明的肽包含(i)具有引发由II类主要组织相容性复合体(MHC)决定簇呈递并且被CD4 + T细胞识别的免疫反应的潜力的抗原(自身或非自身)的T细胞表位 更具体地说是变应原或自体抗原,任选地通过使用接头连接(ii)具有还原活性的氨基酸序列,例如硫还还原酶序列。 已显示本发明的肽可用于药物,更特别用于预防或治疗免疫病症,更具体地说是过敏性病症或自身免疫性疾病。 因此,本发明提供了所述肽在制备用于预防或治疗免疫病症的药物中的用途,并进一步提供了通过使用所述肽治疗或预防免疫病症的方法。 本发明还提供了包含所述肽的组合物。